Primary IgA Nephropathy: New Insights and Emerging Therapies
- 12 July 2024
- journal article
- research article
- Published by Elsevier in Advances in Kidney Disease and Health
- Vol. 31 (3) , 180-193
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative SynthesisPharmacoEconomics - Open, 2023
- Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA NephropathyJAMA Network Open, 2023
- Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA NephropathyJAMA, 2022
- Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA NephropathyKidney International Reports, 2020
- Evaluating a New International Risk-Prediction Tool in IgA NephropathyJAMA Internal Medicine, 2019
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA NephropathyJAMA, 2017
- Salivary Microbiota Associated with Immunoglobulin A NephropathyMicrobial Ecology, 2015
- Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndromeCytokine, 2008
- BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHTCellular Immunology, 2006
- Deposition of polymeric IgA1 in idiopathic mesangial IgA-glomerulonephritisJournal of Molecular Medicine, 1983